# The Effects of Dexmedetomidine and Remifentanil on Carotid Patients

> **NCT00335972** · PHASE4 · TERMINATED · sponsor: **The Cleveland Clinic** · enrollment: 142 (actual)

## Conditions studied

- Carotid Artery Stenosis

## Interventions

- **DRUG:** Remifentanil
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT00335972
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-06
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 142 (ACTUAL)
- **Why stopped:** Closed due to lack of enrollment
- **Last updated:** 2017-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00335972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00335972, "The Effects of Dexmedetomidine and Remifentanil on Carotid Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00335972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*